CPHI
Price
$1.39
Change
-$0.03 (-2.11%)
Updated
Aug 29, 04:53 PM (EDT)
Capitalization
4.63M
HCM
Price
$15.00
Change
+$0.17 (+1.15%)
Updated
Aug 29, 03:59 PM (EDT)
Capitalization
2.63B
77 days until earnings call
Interact to see
Advertisement

CPHI vs HCM

Header iconCPHI vs HCM Comparison
Open Charts CPHI vs HCMBanner chart's image
China Pharma Holdings
Price$1.39
Change-$0.03 (-2.11%)
Volume$230
Capitalization4.63M
HUTCHMED (China)
Price$15.00
Change+$0.17 (+1.15%)
Volume$800
Capitalization2.63B
CPHI vs HCM Comparison Chart in %
Loading...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPHI vs. HCM commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPHI is a Hold and HCM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CPHI: $1.42 vs. HCM: $14.83)
Brand notoriety: CPHI and HCM are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPHI: 65% vs. HCM: 82%
Market capitalization -- CPHI: $4.63M vs. HCM: $2.63B
CPHI [@Pharmaceuticals: Generic] is valued at $4.63M. HCM’s [@Pharmaceuticals: Generic] market capitalization is $2.63B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPHI’s FA Score shows that 0 FA rating(s) are green whileHCM’s FA Score has 0 green FA rating(s).

  • CPHI’s FA Score: 0 green, 5 red.
  • HCM’s FA Score: 0 green, 5 red.
According to our system of comparison, CPHI is a better buy in the long-term than HCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPHI’s TA Score shows that 5 TA indicator(s) are bullish while HCM’s TA Score has 5 bullish TA indicator(s).

  • CPHI’s TA Score: 5 bullish, 4 bearish.
  • HCM’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, CPHI is a better buy in the short-term than HCM.

Price Growth

CPHI (@Pharmaceuticals: Generic) experienced а -4.05% price change this week, while HCM (@Pharmaceuticals: Generic) price change was -7.95% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Reported Earning Dates

HCM is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HCM($2.63B) has a higher market cap than CPHI($4.63M). HCM YTD gains are higher at: 2.915 vs. CPHI (-38.925). HCM has higher annual earnings (EBITDA): 38M vs. CPHI (-1.74M). HCM has more cash in the bank: 1.37B vs. CPHI (625K). CPHI has less debt than HCM: CPHI (3.43M) vs HCM (93.4M). HCM has higher revenues than CPHI: HCM (602M) vs CPHI (4.4M).
CPHIHCMCPHI / HCM
Capitalization4.63M2.63B0%
EBITDA-1.74M38M-5%
Gain YTD-38.9252.915-1,335%
P/E RatioN/A5.60-
Revenue4.4M602M1%
Total Cash625K1.37B0%
Total Debt3.43M93.4M4%
FUNDAMENTALS RATINGS
CPHI vs HCM: Fundamental Ratings
CPHI
HCM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
87
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9163
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CPHI's Valuation (46) in the Pharmaceuticals Generic industry is somewhat better than the same rating for HCM (87) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew somewhat faster than HCM’s over the last 12 months.

CPHI's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as HCM (100) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to HCM’s over the last 12 months.

CPHI's SMR Rating (100) in the Pharmaceuticals Generic industry is in the same range as HCM (100) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to HCM’s over the last 12 months.

HCM's Price Growth Rating (63) in the Pharmaceuticals Major industry is in the same range as CPHI (91) in the Pharmaceuticals Generic industry. This means that HCM’s stock grew similarly to CPHI’s over the last 12 months.

HCM's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that HCM’s stock grew similarly to CPHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPHIHCM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 25 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCTO1.570.08
+5.37%
Eightco Holdings Inc
PL7.210.13
+1.84%
Planet Labs PBC
UFI4.44-0.01
-0.22%
UNIFI
BJ96.79-0.38
-0.39%
BJs Wholesale Club Holdings
KODK5.79-0.07
-1.19%
Eastman Kodak Company

HCM and

Correlation & Price change

A.I.dvisor tells us that HCM and ACET have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCM
1D Price
Change %
HCM100%
-0.87%
ACET - HCM
29%
Poorly correlated
+0.40%
TLRY - HCM
27%
Poorly correlated
+7.30%
CGC - HCM
27%
Poorly correlated
+24.50%
SNDL - HCM
25%
Poorly correlated
+6.32%
IRWD - HCM
24%
Poorly correlated
+4.76%
More